|
1
|
Siegel R, Miller K and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W: Cancer statistics: Updated cancer
burden in China. Chin J Cancer Res. 27:12015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weinberg BA, Marshall JL and Salem ME: The
growing challenge of young adults with colorectal cancer. Oncology
(Williston Park). 31:381–389. 2017.PubMed/NCBI
|
|
5
|
Chen TM, Huang YT and Wang GC: Outcome of
colon cancer initially presenting as colon perforation and
obstruction. World J Surg Oncol. 15:1642017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
You YN, Rustin RB and Sullivan JD:
Oncotype DX(®) colon cancer assay for prediction of
recurrence risk in patients with stage II and III colon cancer: A
review of the evidence. Surg Oncol. 24:61–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pagès F, Mlecnik B, Marliot F, Bindea G,
Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, et al:
International validation of the consensus immunoscore for the
classification of colon cancer: A prognostic and accuracy study.
Lancet. 391:2128–2139. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Simonson B and Das S: MicroRNA
therapeutics: The next magic bullet? Mini Rev Med Chem. 15:467–474.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ritchie W: microRNA target prediction.
Methods Mol Biol. 1513:193–200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu J, Pan X and Hu Z: MiR-502 mediates
esophageal cancer cell TE1 proliferation by promoting AKT
phosphorylation. Biochem Biophys Res Commun. 501:119–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie F, Hosany S, Zhong S, Jiang Y, Zhang
F, Lin L, Wang X, Gao S and Hu X: MicroRNA-193a inhibits breast
cancer proliferation and metastasis by downregulating WT1. PLoS
One. 12:e01855652017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen H, Wang D, Li L, Yang S, Chen X, Zhou
S, Zhong S, Zhao J and Tang J: MiR-222 promotes drug-resistance of
breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1
pathway. Gene. 596:110–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hussein NA, Kholy ZA, Anwar MM, Ahmad MA
and Ahmad SM: Plasma miR-22-3p, miR-642b-3p and miR-885-5p as
diagnostic biomarkers for pancreatic cancer. J Cancer Res Clin
Oncol. 143:83–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paydas S, Acikalin A, Ergin M, Celik H,
Yavuz B and Tanriverdi K: Micro-RNA (miRNA) profile in Hodgkin
lymphoma: Association between clinical and pathological variables.
Med Oncol. 33:342016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stuchbery R, Macintyre G, Cmero M,
Harewood LM, Peters JS, Costello AJ, Hovens CM and Corcoran NM:
Reduction in expression of the benign AR transcriptome is a
hallmark of localised prostate cancer progression. Oncotarget.
7:31384–31392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu L, Zhang C, Li X, Sun W, Qin S, Qin L
and Wang X: miR-223 promotes colon cancer by directly targeting
p120 catenin. Oncotarget. 8:63764–63779. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng M, Zhu L, Li L and Kang C: miR-378
suppresses the proliferation, migration and invasion of colon
cancer cells by inhibiting SDAD1. Cell Mol Biol Lett. 22:122017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fu Q, Cheng J, Zhang J, Zhang Y, Chen X,
Luo S and Xie J: miR-20b reduces 5-FU resistance by suppressing the
ADAM9/EGFR signaling pathway in colon cancer. Oncol Rep.
37:123–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Daniunaite K, Dubikaityte M, Gibas P,
Bakavicius A, Rimantas Lazutka J, Ulys A, Jankevicius F and
Jarmalaite S: Clinical significance of miRNA host gene promoter
methylation in prostate cancer. Hum Mol Genet. 26:2451–2461. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Monterde-Cruz L, Ramirez-Salazar EG,
Rico-Martinez G, Linares-González LM, Guzmán-González R,
Delgado-Cedillo E, Estrada-Villaseñor E, Valdés-Flores M,
Velázquez-Cruz R and Hidalgo-Bravo A: Circulating miR-215-5p and
miR-642a-5p as potential biomarker for diagnosis of osteosarcoma in
Mexican population. Hum Cell. 31:292–299. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marchionni L, Hayashi M, Guida E, Ooki A,
Munari E, Jabboure FJ, Dinalankara W, Raza A, Netto GJ, Hoque MO
and Argani P: MicroRNA expression profiling of Xp11 renal cell
carcinoma. Hum Pathol. 67:18–29. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin C and Zhang Y, Chen Y, Bai Y and Zhang
Y: Long noncoding RNA LINC01234 promotes serine
hydroxymethyltransferase 2 expression and proliferation by
competitively binding miR-642a-5p in colon cancer. Cell Death Dis.
10:1372019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kirkland SC: Type I collagen inhibits
differentiation and promotes a stem cell-like phenotype in human
colorectal carcinoma cells. Br J Cancer. 101:320–326. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia XY, Li WW, Li N, Wu QY, Cui YX and Li
XJ: A novel mild variant of osteogenesis imperfecta type I caused
by a Gly1088Glu mutation in COL1A1. Mol Med Rep. 9:2187–2190. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu S, Liao G and Li G: Regulatory effects
of COL1A1 on apoptosis induced by radiation in cervical cancer
cells. Cancer Cell Int. 17:732017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu J, Shen JX, Wu HT, Li XL, Wen XF, Du
CW and Zhang GJ: Collagen 1A1 (COL1A1) promotes metastasis of
breast cancer and is a potential therapeutic target. Discov Med.
25:211–223. 2018.PubMed/NCBI
|
|
29
|
Ma HP, Chang HL, Bamodu OA, Yadav VK,
Huang TY, Wu ATH, Yeh CT, Tsai SH and Lee WH: Collagen 1A1 (COL1A1)
is a reliable biomarker and putative therapeutic target for
hepatocellular carcinogenesis and metastasis. Cancers (Basel).
11:7862019. View Article : Google Scholar
|
|
30
|
Yang W, Ma J, Zhou W, Li Z, Zhou X, Cao B,
Zhang Y, Liu J, Yang Z, Zhang H, et al: Identification of hub genes
and outcome in colon cancer based on bioinformatics analysis.
Cancer Manag Res. 11:323–338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Z, Wang Y, Zhang J, Zhong J and Yang
R: COL1A1 promotes metastasis in colorectal cancer by regulating
the WNT/PCP pathway. Mol Med Rep. 17:5037–5042. 2018.PubMed/NCBI
|
|
32
|
Du F, Liu H, Lu Y, Zhao X and Fan D:
Epithelial-to-mesenchymal transition: Liaison between cancer
metastasis and drug resistance. Crit Rev Oncog. 22:275–282. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brozovic A: The relationship between
platinum drug resistance and epithelial-mesenchymal transition.
Arch Toxicol. 91:605–619. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mutlu M, Raza U, Saatci Ö, Eyüpoğlu E,
Yurdusev E and Şahin Ö: miR-200c: A versatile watchdog in cancer
progression, EMT, and drug resistance. J Mol Med (Berl).
94:629–644. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada
M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, et al: N-cadherin
expression and epithelial-mesenchymal transition in pancreatic
carcinoma. Clin Cancer Res. 10:4125–4133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang M, Ren D, Guo W, Huang S, Wang Z, Li
Q, Du H, Song L and Peng X: N-cadherin promotes
epithelial-mesenchymal transition and cancer stem cell-like traits
via ErbB signaling in prostate cancer cells. Int J Oncol.
48:595–606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tian H, Lian R, Li Y, Liu C, Liang S, Li
W, Tao T, Wu X, Ye Y, Yang X, et al: AKT-induced lncRNA VAL
promotes EMT-independent metastasis through diminishing
Trim16-dependent vimentin degradation. Nat Commun. 11:51272020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cho SH, Park YS, Kim HJ, Kim CH, Lim SW,
Huh JW, Lee JH and Kim HR: CD44 enhances the epithelial-mesenchymal
transition in association with colon cancer invasion. Int J Oncol.
41:211–218. 2012.PubMed/NCBI
|
|
39
|
Liu J, Eischeid AN and Chen XM: Col1A1
production and apoptotic resistance in TGF-β1-induced
epithelial-to-mesenchymal transition-like phenotype of 603B cells.
PLoS One. 7:e513712012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Watabe M, Kochi M, Nishimaki H, Kano H,
Tamegai H, Shimizu H, Matsuno Y, Kawai T, Masuda S, Sugitani M, et
al: A case of advanced gastric cancer with bone marrow metastasis
treated with low-dose combination chemotherapy containing S-1 and
docetaxel. Gan To Kagaku Ryoho. 46:933–936. 2019.(In Japanese).
PubMed/NCBI
|
